Abstract:BACKGROUND Hepatocellular carcinoma (HCC) is one of the most common types of cancers worldwide, ranking fifth among men and seventh among women, resulting in more than 7 million deaths annually. With the development of medical technology, the 5-year survival rate of HCC patients can be increased to 70%. However, HCC patients are often at increased risk of cardiovascular disease (CVD) death due to exposure to potentially cardiotoxic treatments compared with non-HCC patients. Moreover, CVD and cancer have become major disease burdens worldwide. Thus, further research is needed to lessen the risk of CVD death in HCC patient survivors. AIM To determine the independent risk factors for CVD death in HCC patients and predict cardiovascular mortality (CVM) in HCC patients. METHODS This study was conducted on the basis of the Surveillance, Epidemiology, and End Results database and included HCC patients with a diagnosis period from 2010 to 2015. The independent risk factors were identified using the Fine-Gray model. A nomograph was constructed to predict the CVM in HCC patients. The nomograph performance was measured using Harrell's concordance index (C-index), calibration curve, receiver operating characteristic (ROC) curve, and area under the ROC curve (AUC) value. Moreover, the net benefit was estimated via decision curve analysis (DCA). RESULTS The study included 21545 HCC patients, of whom 619 died of CVD. Age (< 60) [1.981 (1.573-2.496), P 5 cm: 2.090 (1.543-2.830), P < 0.001], surgery (no) [0.376 (0.297-0.476), P < 0.001], and chemotherapy(none/unknown) [0.578 (0.472-0.709), P < 0.001] were independent risk factors for CVD death in HCC patients. The discrimination and calibration of the nomograph were better. The C-index values for the training and validation sets were 0.736 and 0.665, respectively. The AUC values of the ROC curves at 2, 4, and 6 years were 0.702, 0.725, 0.740 in the training set and 0.697, 0.710, 0.744 in the validation set, respectively. The calibration curves showed that the predicted probabilities of the CVM prediction model in the training set vs the validation set were largely consistent with the actual probabilities. DCA demonstrated that the prediction model has a high net benefit. CONCLUSION Risk factors for CVD death in HCC patients were investigated for the first time. The nomograph served as an important reference tool for relevant clinical management decisions.

Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer

[Analysis of Treatment Modalities and Prognosis of Patients with Gallbladder Cancer in China from 2010 to 2017].

Cardiovascular Mortality in Patients with Gynecological Cancers: A Population-based Cohort Study

Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database

Prognostic Factors in Patients with Gallbladder Adenocarcinoma Identified Using Competing-Risks Analysis

Survival and cardiovascular disease mortality among primary liver cancer patients: A population-based study

Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study

Insights From the Analysis of Clinicopathological and Prognostic Factors in Patients With Gallbladder Cancer

The role of marital status in gallbladder cancer: a real-world competing risk analysis

IDDF2024-ABS-0425 Premature Mortality Trends in Gallbladder Cancer: a Global Assessment

Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors

Risk of Primary Liver Cancer Associated with Gallstones and Cholecystectomy A Competing Risks Analysis

Prognostic evaluation in gallbladder carcinoma: Introducing a composite risk model integrating nutritional and immune markers

Competing risk analysis of cardiovascular mortality in multiple myeloma survivors

Risk Factors and Prognosis of Liver Metastasis in Gallbladder Cancer Patients: A SEER-based Study

High cardiovascular mortality risk among older merkel cell carcinoma patients

Risk of cardiovascular death in patients with hepatocellular carcinoma based on the Fine-Gray model

Cardiovascular Outcomes in the Patients with Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World

Effects of cytoreductive surgery combined with hyperthermic perfusion chemotherapy on prognosis of patients with advanced gallbladder cancer

Several Important Issues on Diagnosis and Treatment of Primary Gallbladder Carcinoma

Gallbladder carcinoma: analysis of prognostic factors in 132 cases.